Monkeypox Outbreak May End In Europe Who Says As Cases Drop

Comment A slowdown in monkeypox cases has boosted confidence that the epidemic can be eradicated in Europe, World Health Organization officials said on Tuesday. Despite limited vaccine supplies, many European countries — including France, Germany, Portugal, Spain and the United Kingdom — have seen steady weekly declines in new infections. Some regions of the United States also reported a slowdown. Officials ‘cautiously optimistic’ about falling monkeypox cases “We believe we can eliminate ongoing human-to-human transmission of monkeypox in the region,” Hans Kluge, WHO regional director for Europe, told an online press briefing on Tuesday. “To move towards eradication in our region, we must urgently step up our efforts.” Kluge cited the example of Portugal, where government efforts to raise awareness have prompted people “to take precautions and modify their behavior, resulting in better health outcomes and helping to contain the epidemic.” Europe, which has confirmed more than 22,000 cases of monkeypox (more than a third of the global toll), has so far approved a smallpox vaccine, a smallpox vaccine from the Danish company Bavarian Nordic and marketed in Europe as Imvanex , but the offer is limited Worldwide. UK, EU and US regulators have approved intradermal vaccination, which uses a fifth of the traditional vaccine dose by injecting the vaccine under the first layer of skin, increasing the existing stock fivefold. In some European countries, vaccination prioritizes LGBT sex workers who are considered particularly at risk. Monkeypox broke out in Europe in early May after outbreaks were reported in some African countries. The WHO declared the outbreak a public health emergency 10 weeks later. What you need to know about monkeypox symptoms, treatments and protection The recent slowdown in European cases could be due to early detection and isolation, said Catherine Smallwood, monkeypox case manager at the WHO’s Europe office. “We have some pretty good anecdotal evidence that people — particularly men who have sex with men, who are in certain risk groups — are much more knowledgeable about the disease,” Smallwood said in a briefing. “We have to build on that … and we strongly believe that if we continue to do that, we will be able to sustain this decline,” he said. There are early signs that rates of new infections are also slowing in some major US cities hit by outbreaks, especially New York, Chicago and San Francisco. The United States recorded a daily average of 337 new cases last week, down about 25 percent from two weeks earlier, according to the Washington Post’s seven-day rolling average, though officials cautioned against overoptimism. “The rate of increase is lower, but we’re still seeing increases, and of course we’re a very diverse country and things aren’t even across the country,” Rochelle Walensky, director of the US Centers for Disease Control and Prevention, told reporters. Friday.

title: “Monkeypox Outbreak May End In Europe Who Says As Cases Drop Klmat” ShowToc: true date: “2022-12-09” author: “Virginia Hill”

Comment A slowdown in monkeypox cases has boosted confidence that the epidemic can be eradicated in Europe, World Health Organization officials said on Tuesday. Despite limited vaccine supplies, many European countries — including France, Germany, Portugal, Spain and the United Kingdom — have seen steady weekly declines in new infections. Some regions of the United States also reported a slowdown. Officials ‘cautiously optimistic’ about falling monkeypox cases “We believe we can eliminate ongoing human-to-human transmission of monkeypox in the region,” Hans Kluge, WHO regional director for Europe, told an online press briefing on Tuesday. “To move towards eradication in our region, we must urgently step up our efforts.” Kluge cited the example of Portugal, where government efforts to raise awareness have prompted people “to take precautions and modify their behavior, resulting in better health outcomes and helping to contain the epidemic.” Europe, which has confirmed more than 22,000 cases of monkeypox (more than a third of the global toll), has so far approved a smallpox vaccine, a smallpox vaccine from the Danish company Bavarian Nordic and marketed in Europe as Imvanex , but the offer is limited Worldwide. UK, EU and US regulators have approved intradermal vaccination, which uses a fifth of the traditional vaccine dose by injecting the vaccine under the first layer of skin, increasing the existing stock fivefold. In some European countries, vaccination prioritizes LGBT sex workers who are considered particularly at risk. Monkeypox broke out in Europe in early May after outbreaks were reported in some African countries. The WHO declared the outbreak a public health emergency 10 weeks later. What you need to know about monkeypox symptoms, treatments and protection The recent slowdown in European cases could be due to early detection and isolation, said Catherine Smallwood, monkeypox case manager at the WHO’s Europe office. “We have some pretty good anecdotal evidence that people — particularly men who have sex with men, who are in certain risk groups — are much more knowledgeable about the disease,” Smallwood said in a briefing. “We have to build on that … and we strongly believe that if we continue to do that, we will be able to sustain this decline,” he said. There are early signs that rates of new infections are also slowing in some major US cities hit by outbreaks, especially New York, Chicago and San Francisco. The United States recorded a daily average of 337 new cases last week, down about 25 percent from two weeks earlier, according to the Washington Post’s seven-day rolling average, though officials cautioned against overoptimism. “The rate of increase is lower, but we’re still seeing increases, and of course we’re a very diverse country and things aren’t even across the country,” Rochelle Walensky, director of the US Centers for Disease Control and Prevention, told reporters. Friday.

title: “Monkeypox Outbreak May End In Europe Who Says As Cases Drop Klmat” ShowToc: true date: “2022-12-11” author: “Joseph Dipasquale”

Comment A slowdown in monkeypox cases has boosted confidence that the epidemic can be eradicated in Europe, World Health Organization officials said on Tuesday. Despite limited vaccine supplies, many European countries — including France, Germany, Portugal, Spain and the United Kingdom — have seen steady weekly declines in new infections. Some regions of the United States also reported a slowdown. Officials ‘cautiously optimistic’ about falling monkeypox cases “We believe we can eliminate ongoing human-to-human transmission of monkeypox in the region,” Hans Kluge, WHO regional director for Europe, told an online press briefing on Tuesday. “To move towards eradication in our region, we must urgently step up our efforts.” Kluge cited the example of Portugal, where government efforts to raise awareness have prompted people “to take precautions and modify their behavior, resulting in better health outcomes and helping to contain the epidemic.” Europe, which has confirmed more than 22,000 cases of monkeypox (more than a third of the global toll), has so far approved a smallpox vaccine, a smallpox vaccine from the Danish company Bavarian Nordic and marketed in Europe as Imvanex , but the offer is limited Worldwide. UK, EU and US regulators have approved intradermal vaccination, which uses a fifth of the traditional vaccine dose by injecting the vaccine under the first layer of skin, increasing the existing stock fivefold. In some European countries, vaccination prioritizes LGBT sex workers who are considered particularly at risk. Monkeypox broke out in Europe in early May after outbreaks were reported in some African countries. The WHO declared the outbreak a public health emergency 10 weeks later. What you need to know about monkeypox symptoms, treatments and protection The recent slowdown in European cases could be due to early detection and isolation, said Catherine Smallwood, monkeypox case manager at the WHO’s Europe office. “We have some pretty good anecdotal evidence that people — particularly men who have sex with men, who are in certain risk groups — are much more knowledgeable about the disease,” Smallwood said in a briefing. “We have to build on that … and we strongly believe that if we continue to do that, we will be able to sustain this decline,” he said. There are early signs that rates of new infections are also slowing in some major US cities hit by outbreaks, especially New York, Chicago and San Francisco. The United States recorded a daily average of 337 new cases last week, down about 25 percent from two weeks earlier, according to the Washington Post’s seven-day rolling average, though officials cautioned against overoptimism. “The rate of increase is lower, but we’re still seeing increases, and of course we’re a very diverse country and things aren’t even across the country,” Rochelle Walensky, director of the US Centers for Disease Control and Prevention, told reporters. Friday.

title: “Monkeypox Outbreak May End In Europe Who Says As Cases Drop Klmat” ShowToc: true date: “2022-10-23” author: “Mark Odell”

Comment A slowdown in monkeypox cases has boosted confidence that the epidemic can be eradicated in Europe, World Health Organization officials said on Tuesday. Despite limited vaccine supplies, many European countries — including France, Germany, Portugal, Spain and the United Kingdom — have seen steady weekly declines in new infections. Some regions of the United States also reported a slowdown. Officials ‘cautiously optimistic’ about falling monkeypox cases “We believe we can eliminate ongoing human-to-human transmission of monkeypox in the region,” Hans Kluge, WHO regional director for Europe, told an online press briefing on Tuesday. “To move towards eradication in our region, we must urgently step up our efforts.” Kluge cited the example of Portugal, where government efforts to raise awareness have prompted people “to take precautions and modify their behavior, resulting in better health outcomes and helping to contain the epidemic.” Europe, which has confirmed more than 22,000 cases of monkeypox (more than a third of the global toll), has so far approved a smallpox vaccine, a smallpox vaccine from the Danish company Bavarian Nordic and marketed in Europe as Imvanex , but the offer is limited Worldwide. UK, EU and US regulators have approved intradermal vaccination, which uses a fifth of the traditional vaccine dose by injecting the vaccine under the first layer of skin, increasing the existing stock fivefold. In some European countries, vaccination prioritizes LGBT sex workers who are considered particularly at risk. Monkeypox broke out in Europe in early May after outbreaks were reported in some African countries. The WHO declared the outbreak a public health emergency 10 weeks later. What you need to know about monkeypox symptoms, treatments and protection The recent slowdown in European cases could be due to early detection and isolation, said Catherine Smallwood, monkeypox case manager at the WHO’s Europe office. “We have some pretty good anecdotal evidence that people — particularly men who have sex with men, who are in certain risk groups — are much more knowledgeable about the disease,” Smallwood said in a briefing. “We have to build on that … and we strongly believe that if we continue to do that, we will be able to sustain this decline,” he said. There are early signs that rates of new infections are also slowing in some major US cities hit by outbreaks, especially New York, Chicago and San Francisco. The United States recorded a daily average of 337 new cases last week, down about 25 percent from two weeks earlier, according to the Washington Post’s seven-day rolling average, though officials cautioned against overoptimism. “The rate of increase is lower, but we’re still seeing increases, and of course we’re a very diverse country and things aren’t even across the country,” Rochelle Walensky, director of the US Centers for Disease Control and Prevention, told reporters. Friday.